Enanta Pharmaceuticals (ENTA) Research & Development: 2012-2025
Historic Research & Development for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Sep 2025 value amounting to $23.8 million.
- Enanta Pharmaceuticals' Research & Development fell 22.64% to $23.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $106.7 million, marking a year-over-year decrease of 18.81%. This contributed to the annual value of $106.7 million for FY2025, which is 18.81% down from last year.
- Enanta Pharmaceuticals' Research & Development amounted to $23.8 million in Q3 2025, which was down 12.50% from $27.2 million recorded in Q2 2025.
- In the past 5 years, Enanta Pharmaceuticals' Research & Development ranged from a high of $48.9 million in Q3 2021 and a low of $23.8 million during Q3 2025.
- Over the past 3 years, Enanta Pharmaceuticals' median Research & Development value was $30.8 million (recorded in 2024), while the average stood at $32.8 million.
- In the last 5 years, Enanta Pharmaceuticals' Research & Development spiked by 35.50% in 2021 and then tumbled by 33.14% in 2024.
- Quarterly analysis of 5 years shows Enanta Pharmaceuticals' Research & Development stood at $48.5 million in 2021, then decreased by 15.75% to $40.9 million in 2022, then dropped by 11.08% to $36.4 million in 2023, then dropped by 23.96% to $27.7 million in 2024, then dropped by 22.64% to $23.8 million in 2025.
- Its last three reported values are $23.8 million in Q3 2025, $27.2 million for Q2 2025, and $28.1 million during Q1 2025.